世界の緑内障用点眼薬市場2022年:市場規模予測(~2028年)

■ 英語タイトル:Global Eye Drops for Glaucoma Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート(データ管理コード:GIR22NO19309)■ 発行会社/調査会社:GlobalInfoResearch
■ 商品コード:GIR22NO19309
■ 発行日:2022年11月(※2025年版があります。お問い合わせください。)
■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:102
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(注文後2-3日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の緑内障用点眼薬市場2022年:市場規模予測(~2028年)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

緑内障用点眼薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の緑内障用点眼薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

緑内障用点眼薬市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ビマトプロスト、ラタノプロスト、タフルプロスト、トラボプロスト

用途別セグメントは次のように区分されます。
・病院、眼科、薬局、その他

世界の緑内障用点眼薬市場の主要な市場プレーヤーは以下のとおりです。
・Thea Pharmaceuticals Ltd、FDC International Ltd、Martindale Pharma、Zentiva、Upjohn UK Limited、Beacon Pharmaceuticals、Novartis Pharmaceuticals UK Ltd、Mylan、Accord Healthcare Limited、Sandoz Limited、Thornton & Ross Ltd、Aspire Pharma Ltd、AbbVie Ltd

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、緑内障用点眼薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な緑内障用点眼薬メーカーの企業概要、2019年~2022年までの緑内障用点眼薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な緑内障用点眼薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別緑内障用点眼薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの緑内障用点眼薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での緑内障用点眼薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および緑内障用点眼薬の産業チェーンを掲載しています。
・第13、14、15章では、緑内障用点眼薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 緑内障用点眼薬の概要
- 種類別分析(2017年vs2021年vs2028年):ビマトプロスト、ラタノプロスト、タフルプロスト、トラボプロスト
- 用途別分析(2017年vs2021年vs2028年):病院、眼科、薬局、その他
- 世界の緑内障用点眼薬市場規模・予測
- 世界の緑内障用点眼薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Thea Pharmaceuticals Ltd、FDC International Ltd、Martindale Pharma、Zentiva、Upjohn UK Limited、Beacon Pharmaceuticals、Novartis Pharmaceuticals UK Ltd、Mylan、Accord Healthcare Limited、Sandoz Limited、Thornton & Ross Ltd、Aspire Pharma Ltd、AbbVie Ltd
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:ビマトプロスト、ラタノプロスト、タフルプロスト、トラボプロスト
・用途別分析2017年-2028年:病院、眼科、薬局、その他
・緑内障用点眼薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・緑内障用点眼薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・緑内障用点眼薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・緑内障用点眼薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・緑内障用点眼薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Eye Drops for Glaucoma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Eye Drops for Glaucoma market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital accounting for % of the Eye Drops for Glaucoma global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Bimatoprost segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Eye Drops for Glaucoma include Thea Pharmaceuticals Ltd, FDC International Ltd, Martindale Pharma, Zentiva, and Upjohn UK Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Eye Drops for Glaucoma market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bimatoprost
Latanoprost
Tafluprost
Travoprost
Market segment by Application can be divided into
Hospital
Ophthalmic Clinic
Pharmacy
Others
The key market players for global Eye Drops for Glaucoma market are listed below:
Thea Pharmaceuticals Ltd
FDC International Ltd
Martindale Pharma
Zentiva
Upjohn UK Limited
Beacon Pharmaceuticals
Novartis Pharmaceuticals UK Ltd
Mylan
Accord Healthcare Limited
Sandoz Limited
Thornton & Ross Ltd
Aspire Pharma Ltd
AbbVie Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eye Drops for Glaucoma product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Eye Drops for Glaucoma, with price, sales, revenue and global market share of Eye Drops for Glaucoma from 2019 to 2022.
Chapter 3, the Eye Drops for Glaucoma competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eye Drops for Glaucoma breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Eye Drops for Glaucoma market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Eye Drops for Glaucoma.
Chapter 13, 14, and 15, to describe Eye Drops for Glaucoma sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次(コンテンツ)***

1 Market Overview
1.1 Eye Drops for Glaucoma Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Eye Drops for Glaucoma Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Bimatoprost
1.2.3 Latanoprost
1.2.4 Tafluprost
1.2.5 Travoprost
1.3 Market Analysis by Application
1.3.1 Overview: Global Eye Drops for Glaucoma Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Ophthalmic Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Global Eye Drops for Glaucoma Market Size & Forecast
1.4.1 Global Eye Drops for Glaucoma Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Eye Drops for Glaucoma Sales in Volume (2017-2028)
1.4.3 Global Eye Drops for Glaucoma Price (2017-2028)
1.5 Global Eye Drops for Glaucoma Production Capacity Analysis
1.5.1 Global Eye Drops for Glaucoma Total Production Capacity (2017-2028)
1.5.2 Global Eye Drops for Glaucoma Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Eye Drops for Glaucoma Market Drivers
1.6.2 Eye Drops for Glaucoma Market Restraints
1.6.3 Eye Drops for Glaucoma Trends Analysis
2 Manufacturers Profiles
2.1 Thea Pharmaceuticals Ltd
2.1.1 Thea Pharmaceuticals Ltd Details
2.1.2 Thea Pharmaceuticals Ltd Major Business
2.1.3 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product and Services
2.1.4 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 FDC International Ltd
2.2.1 FDC International Ltd Details
2.2.2 FDC International Ltd Major Business
2.2.3 FDC International Ltd Eye Drops for Glaucoma Product and Services
2.2.4 FDC International Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Martindale Pharma
2.3.1 Martindale Pharma Details
2.3.2 Martindale Pharma Major Business
2.3.3 Martindale Pharma Eye Drops for Glaucoma Product and Services
2.3.4 Martindale Pharma Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Zentiva
2.4.1 Zentiva Details
2.4.2 Zentiva Major Business
2.4.3 Zentiva Eye Drops for Glaucoma Product and Services
2.4.4 Zentiva Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Upjohn UK Limited
2.5.1 Upjohn UK Limited Details
2.5.2 Upjohn UK Limited Major Business
2.5.3 Upjohn UK Limited Eye Drops for Glaucoma Product and Services
2.5.4 Upjohn UK Limited Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Beacon Pharmaceuticals
2.6.1 Beacon Pharmaceuticals Details
2.6.2 Beacon Pharmaceuticals Major Business
2.6.3 Beacon Pharmaceuticals Eye Drops for Glaucoma Product and Services
2.6.4 Beacon Pharmaceuticals Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis Pharmaceuticals UK Ltd
2.7.1 Novartis Pharmaceuticals UK Ltd Details
2.7.2 Novartis Pharmaceuticals UK Ltd Major Business
2.7.3 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product and Services
2.7.4 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Eye Drops for Glaucoma Product and Services
2.8.4 Mylan Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Accord Healthcare Limited
2.9.1 Accord Healthcare Limited Details
2.9.2 Accord Healthcare Limited Major Business
2.9.3 Accord Healthcare Limited Eye Drops for Glaucoma Product and Services
2.9.4 Accord Healthcare Limited Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Sandoz Limited
2.10.1 Sandoz Limited Details
2.10.2 Sandoz Limited Major Business
2.10.3 Sandoz Limited Eye Drops for Glaucoma Product and Services
2.10.4 Sandoz Limited Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Thornton & Ross Ltd
2.11.1 Thornton & Ross Ltd Details
2.11.2 Thornton & Ross Ltd Major Business
2.11.3 Thornton & Ross Ltd Eye Drops for Glaucoma Product and Services
2.11.4 Thornton & Ross Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Aspire Pharma Ltd
2.12.1 Aspire Pharma Ltd Details
2.12.2 Aspire Pharma Ltd Major Business
2.12.3 Aspire Pharma Ltd Eye Drops for Glaucoma Product and Services
2.12.4 Aspire Pharma Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 AbbVie Ltd
2.13.1 AbbVie Ltd Details
2.13.2 AbbVie Ltd Major Business
2.13.3 AbbVie Ltd Eye Drops for Glaucoma Product and Services
2.13.4 AbbVie Ltd Eye Drops for Glaucoma Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Eye Drops for Glaucoma Breakdown Data by Manufacturer
3.1 Global Eye Drops for Glaucoma Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Eye Drops for Glaucoma Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Eye Drops for Glaucoma
3.4 Market Concentration Rate
3.4.1 Top 3 Eye Drops for Glaucoma Manufacturer Market Share in 2021
3.4.2 Top 6 Eye Drops for Glaucoma Manufacturer Market Share in 2021
3.5 Global Eye Drops for Glaucoma Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Eye Drops for Glaucoma Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Eye Drops for Glaucoma Market Size by Region
4.1.1 Global Eye Drops for Glaucoma Sales in Volume by Region (2017-2028)
4.1.2 Global Eye Drops for Glaucoma Revenue by Region (2017-2028)
4.2 North America Eye Drops for Glaucoma Revenue (2017-2028)
4.3 Europe Eye Drops for Glaucoma Revenue (2017-2028)
4.4 Asia-Pacific Eye Drops for Glaucoma Revenue (2017-2028)
4.5 South America Eye Drops for Glaucoma Revenue (2017-2028)
4.6 Middle East and Africa Eye Drops for Glaucoma Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Eye Drops for Glaucoma Sales in Volume by Type (2017-2028)
5.2 Global Eye Drops for Glaucoma Revenue by Type (2017-2028)
5.3 Global Eye Drops for Glaucoma Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Eye Drops for Glaucoma Sales in Volume by Application (2017-2028)
6.2 Global Eye Drops for Glaucoma Revenue by Application (2017-2028)
6.3 Global Eye Drops for Glaucoma Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Eye Drops for Glaucoma Sales by Type (2017-2028)
7.2 North America Eye Drops for Glaucoma Sales by Application (2017-2028)
7.3 North America Eye Drops for Glaucoma Market Size by Country
7.3.1 North America Eye Drops for Glaucoma Sales in Volume by Country (2017-2028)
7.3.2 North America Eye Drops for Glaucoma Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Eye Drops for Glaucoma Sales by Type (2017-2028)
8.2 Europe Eye Drops for Glaucoma Sales by Application (2017-2028)
8.3 Europe Eye Drops for Glaucoma Market Size by Country
8.3.1 Europe Eye Drops for Glaucoma Sales in Volume by Country (2017-2028)
8.3.2 Europe Eye Drops for Glaucoma Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Eye Drops for Glaucoma Sales by Type (2017-2028)
9.2 Asia-Pacific Eye Drops for Glaucoma Sales by Application (2017-2028)
9.3 Asia-Pacific Eye Drops for Glaucoma Market Size by Region
9.3.1 Asia-Pacific Eye Drops for Glaucoma Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Eye Drops for Glaucoma Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Eye Drops for Glaucoma Sales by Type (2017-2028)
10.2 South America Eye Drops for Glaucoma Sales by Application (2017-2028)
10.3 South America Eye Drops for Glaucoma Market Size by Country
10.3.1 South America Eye Drops for Glaucoma Sales in Volume by Country (2017-2028)
10.3.2 South America Eye Drops for Glaucoma Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Eye Drops for Glaucoma Sales by Type (2017-2028)
11.2 Middle East & Africa Eye Drops for Glaucoma Sales by Application (2017-2028)
11.3 Middle East & Africa Eye Drops for Glaucoma Market Size by Country
11.3.1 Middle East & Africa Eye Drops for Glaucoma Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Eye Drops for Glaucoma Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Eye Drops for Glaucoma and Key Manufacturers
12.2 Manufacturing Costs Percentage of Eye Drops for Glaucoma
12.3 Eye Drops for Glaucoma Production Process
12.4 Eye Drops for Glaucoma Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Eye Drops for Glaucoma Typical Distributors
13.3 Eye Drops for Glaucoma Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Eye Drops for Glaucoma Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Eye Drops for Glaucoma Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Thea Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Thea Pharmaceuticals Ltd Major Business
Table 5. Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product and Services
Table 6. Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. FDC International Ltd Basic Information, Manufacturing Base and Competitors
Table 8. FDC International Ltd Major Business
Table 9. FDC International Ltd Eye Drops for Glaucoma Product and Services
Table 10. FDC International Ltd Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Martindale Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Martindale Pharma Major Business
Table 13. Martindale Pharma Eye Drops for Glaucoma Product and Services
Table 14. Martindale Pharma Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Zentiva Basic Information, Manufacturing Base and Competitors
Table 16. Zentiva Major Business
Table 17. Zentiva Eye Drops for Glaucoma Product and Services
Table 18. Zentiva Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Upjohn UK Limited Basic Information, Manufacturing Base and Competitors
Table 20. Upjohn UK Limited Major Business
Table 21. Upjohn UK Limited Eye Drops for Glaucoma Product and Services
Table 22. Upjohn UK Limited Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Beacon Pharmaceuticals Major Business
Table 25. Beacon Pharmaceuticals Eye Drops for Glaucoma Product and Services
Table 26. Beacon Pharmaceuticals Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis Pharmaceuticals UK Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Pharmaceuticals UK Ltd Major Business
Table 29. Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product and Services
Table 30. Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Eye Drops for Glaucoma Product and Services
Table 34. Mylan Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Accord Healthcare Limited Basic Information, Manufacturing Base and Competitors
Table 36. Accord Healthcare Limited Major Business
Table 37. Accord Healthcare Limited Eye Drops for Glaucoma Product and Services
Table 38. Accord Healthcare Limited Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Sandoz Limited Basic Information, Manufacturing Base and Competitors
Table 40. Sandoz Limited Major Business
Table 41. Sandoz Limited Eye Drops for Glaucoma Product and Services
Table 42. Sandoz Limited Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Thornton & Ross Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Thornton & Ross Ltd Major Business
Table 45. Thornton & Ross Ltd Eye Drops for Glaucoma Product and Services
Table 46. Thornton & Ross Ltd Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Aspire Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 48. Aspire Pharma Ltd Major Business
Table 49. Aspire Pharma Ltd Eye Drops for Glaucoma Product and Services
Table 50. Aspire Pharma Ltd Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. AbbVie Ltd Basic Information, Manufacturing Base and Competitors
Table 52. AbbVie Ltd Major Business
Table 53. AbbVie Ltd Eye Drops for Glaucoma Product and Services
Table 54. AbbVie Ltd Eye Drops for Glaucoma Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Eye Drops for Glaucoma Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 56. Global Eye Drops for Glaucoma Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Eye Drops for Glaucoma, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Eye Drops for Glaucoma Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Eye Drops for Glaucoma Production Site of Key Manufacturer
Table 60. Eye Drops for Glaucoma New Entrant and Capacity Expansion Plans
Table 61. Eye Drops for Glaucoma Mergers & Acquisitions in the Past Five Years
Table 62. Global Eye Drops for Glaucoma Sales by Region (2017-2022) & (K Units)
Table 63. Global Eye Drops for Glaucoma Sales by Region (2023-2028) & (K Units)
Table 64. Global Eye Drops for Glaucoma Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Eye Drops for Glaucoma Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 67. Global Eye Drops for Glaucoma Sales by Type (2023-2028) & (K Units)
Table 68. Global Eye Drops for Glaucoma Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Eye Drops for Glaucoma Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Eye Drops for Glaucoma Price by Type (2017-2022) & (US$/Unit)
Table 71. Global Eye Drops for Glaucoma Price by Type (2023-2028) & (US$/Unit)
Table 72. Global Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 73. Global Eye Drops for Glaucoma Sales by Application (2023-2028) & (K Units)
Table 74. Global Eye Drops for Glaucoma Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Eye Drops for Glaucoma Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Eye Drops for Glaucoma Price by Application (2017-2022) & (US$/Unit)
Table 77. Global Eye Drops for Glaucoma Price by Application (2023-2028) & (US$/Unit)
Table 78. North America Eye Drops for Glaucoma Sales by Country (2017-2022) & (K Units)
Table 79. North America Eye Drops for Glaucoma Sales by Country (2023-2028) & (K Units)
Table 80. North America Eye Drops for Glaucoma Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Eye Drops for Glaucoma Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 83. North America Eye Drops for Glaucoma Sales by Type (2023-2028) & (K Units)
Table 84. North America Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 85. North America Eye Drops for Glaucoma Sales by Application (2023-2028) & (K Units)
Table 86. Europe Eye Drops for Glaucoma Sales by Country (2017-2022) & (K Units)
Table 87. Europe Eye Drops for Glaucoma Sales by Country (2023-2028) & (K Units)
Table 88. Europe Eye Drops for Glaucoma Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Eye Drops for Glaucoma Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 91. Europe Eye Drops for Glaucoma Sales by Type (2023-2028) & (K Units)
Table 92. Europe Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 93. Europe Eye Drops for Glaucoma Sales by Application (2023-2028) & (K Units)
Table 94. Asia-Pacific Eye Drops for Glaucoma Sales by Region (2017-2022) & (K Units)
Table 95. Asia-Pacific Eye Drops for Glaucoma Sales by Region (2023-2028) & (K Units)
Table 96. Asia-Pacific Eye Drops for Glaucoma Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Eye Drops for Glaucoma Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 99. Asia-Pacific Eye Drops for Glaucoma Sales by Type (2023-2028) & (K Units)
Table 100. Asia-Pacific Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 101. Asia-Pacific Eye Drops for Glaucoma Sales by Application (2023-2028) & (K Units)
Table 102. South America Eye Drops for Glaucoma Sales by Country (2017-2022) & (K Units)
Table 103. South America Eye Drops for Glaucoma Sales by Country (2023-2028) & (K Units)
Table 104. South America Eye Drops for Glaucoma Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Eye Drops for Glaucoma Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 107. South America Eye Drops for Glaucoma Sales by Type (2023-2028) & (K Units)
Table 108. South America Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 109. South America Eye Drops for Glaucoma Sales by Application (2023-2028) & (K Units)
Table 110. Middle East & Africa Eye Drops for Glaucoma Sales by Region (2017-2022) & (K Units)
Table 111. Middle East & Africa Eye Drops for Glaucoma Sales by Region (2023-2028) & (K Units)
Table 112. Middle East & Africa Eye Drops for Glaucoma Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Eye Drops for Glaucoma Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 115. Middle East & Africa Eye Drops for Glaucoma Sales by Type (2023-2028) & (K Units)
Table 116. Middle East & Africa Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 117. Middle East & Africa Eye Drops for Glaucoma Sales by Application (2023-2028) & (K Units)
Table 118. Eye Drops for Glaucoma Raw Material
Table 119. Key Manufacturers of Eye Drops for Glaucoma Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Eye Drops for Glaucoma Typical Distributors
Table 123. Eye Drops for Glaucoma Typical Customers
List of Figures
Figure 1. Eye Drops for Glaucoma Picture
Figure 2. Global Eye Drops for Glaucoma Revenue Market Share by Type in 2021
Figure 3. Bimatoprost
Figure 4. Latanoprost
Figure 5. Tafluprost
Figure 6. Travoprost
Figure 7. Global Eye Drops for Glaucoma Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Ophthalmic Clinic
Figure 10. Pharmacy
Figure 11. Others
Figure 12. Global Eye Drops for Glaucoma Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Eye Drops for Glaucoma Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Eye Drops for Glaucoma Sales (2017-2028) & (K Units)
Figure 15. Global Eye Drops for Glaucoma Price (2017-2028) & (US$/Unit)
Figure 16. Global Eye Drops for Glaucoma Production Capacity (2017-2028) & (K Units)
Figure 17. Global Eye Drops for Glaucoma Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Eye Drops for Glaucoma Market Drivers
Figure 19. Eye Drops for Glaucoma Market Restraints
Figure 20. Eye Drops for Glaucoma Market Trends
Figure 21. Global Eye Drops for Glaucoma Sales Market Share by Manufacturer in 2021
Figure 22. Global Eye Drops for Glaucoma Revenue Market Share by Manufacturer in 2021
Figure 23. Eye Drops for Glaucoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Eye Drops for Glaucoma Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Eye Drops for Glaucoma Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Eye Drops for Glaucoma Sales Market Share by Region (2017-2028)
Figure 27. Global Eye Drops for Glaucoma Revenue Market Share by Region (2017-2028)
Figure 28. North America Eye Drops for Glaucoma Revenue (2017-2028) & (USD Million)
Figure 29. Europe Eye Drops for Glaucoma Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Eye Drops for Glaucoma Revenue (2017-2028) & (USD Million)
Figure 31. South America Eye Drops for Glaucoma Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Eye Drops for Glaucoma Revenue (2017-2028) & (USD Million)
Figure 33. Global Eye Drops for Glaucoma Sales Market Share by Type (2017-2028)
Figure 34. Global Eye Drops for Glaucoma Revenue Market Share by Type (2017-2028)
Figure 35. Global Eye Drops for Glaucoma Price by Type (2017-2028) & (US$/Unit)
Figure 36. Global Eye Drops for Glaucoma Sales Market Share by Application (2017-2028)
Figure 37. Global Eye Drops for Glaucoma Revenue Market Share by Application (2017-2028)
Figure 38. Global Eye Drops for Glaucoma Price by Application (2017-2028) & (US$/Unit)
Figure 39. North America Eye Drops for Glaucoma Sales Market Share by Type (2017-2028)
Figure 40. North America Eye Drops for Glaucoma Sales Market Share by Application (2017-2028)
Figure 41. North America Eye Drops for Glaucoma Sales Market Share by Country (2017-2028)
Figure 42. North America Eye Drops for Glaucoma Revenue Market Share by Country (2017-2028)
Figure 43. United States Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Eye Drops for Glaucoma Sales Market Share by Type (2017-2028)
Figure 47. Europe Eye Drops for Glaucoma Sales Market Share by Application (2017-2028)
Figure 48. Europe Eye Drops for Glaucoma Sales Market Share by Country (2017-2028)
Figure 49. Europe Eye Drops for Glaucoma Revenue Market Share by Country (2017-2028)
Figure 50. Germany Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Eye Drops for Glaucoma Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Eye Drops for Glaucoma Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Eye Drops for Glaucoma Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Eye Drops for Glaucoma Revenue Market Share by Region (2017-2028)
Figure 59. China Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Eye Drops for Glaucoma Sales Market Share by Type (2017-2028)
Figure 66. South America Eye Drops for Glaucoma Sales Market Share by Application (2017-2028)
Figure 67. South America Eye Drops for Glaucoma Sales Market Share by Country (2017-2028)
Figure 68. South America Eye Drops for Glaucoma Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Eye Drops for Glaucoma Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Eye Drops for Glaucoma Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Eye Drops for Glaucoma in 2021
Figure 80. Manufacturing Process Analysis of Eye Drops for Glaucoma
Figure 81. Eye Drops for Glaucoma Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GIR22NO19309 )"世界の緑内障用点眼薬市場2022年:市場規模予測(~2028年)" (英文:Global Eye Drops for Glaucoma Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。